Evidence map›Paper›PMID 39506193›Full record

ReviewClinical and translational allergy2024

GA

Torsten Zuberbier, Antonella Muraro, Ulugbek Nurmatov, Stefania Arasi, Katarina Stevanovic, Aikaterini Anagnostou, Roberta Bonaguro, Sharon Chinthrajah, Gideon Lack, Alessandro Fiocchi and 46 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical and translational allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. The Expanding Role of Omalizumab: From Food Allergy to Drug Desensitization.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Review
  9. Common data elements for food allergy clinical trials: an overview.Current opinion in allergy and clinical immunology · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. GAClinical and translational allergy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Torsten ZuberbierInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-1466-8875
Antonella MuraroFood Allergy Referral Centre, Department of Women and Children Health, Padua University Hospital, Padua, Italy.ORCID https://orcid.org/0000-0002-5026-5862
Ulugbek NurmatovDivision of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Stefania ArasiAllergy Unit, Pediatric Hospital Bambino Gesù IRCCS, Rome, Italy.
Katarina StevanovicInstitute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Aikaterini AnagnostouDepartment of Pediatrics, Division of Allergy and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Roberta BonaguroFood Allergy Referral Centre, Department of Women and Children Health, Padua University Hospital, Padua, Italy.
Sharon ChinthrajahSean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, California, USA.
Gideon LackPaediatric Allergy, King's College London, London, UK.
Alessandro FiocchiAllergy Unit, Pediatric Hospital Bambino Gesù IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-2549-0523
Thuy-My LeDepartment of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Paul TurnerImperial College London, London, UK.
Montserrat Alvaro LozanoPediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Elizabeth AngierPrimary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Simona BarniAllergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Phillippe BéginSection of Allergy and Clinical Immunology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Barbara Ballmer-WeberClinic for Dermatology and Allergology, St. Gallen, Switzerland.
Victoria CardonaAllergy Section, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Carsten Bindslev-JensenDepartment of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0002-8940-038X
Antonella CianferoniAllergy and Immunology Division, Perelman School of Medicine, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nicolette de JongInternal Medicine, Allergology & Clinical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-7216-0906
Debra de SilvaThe Evidence Centre, London, UK.ORCID https://orcid.org/0000-0001-8413-5487
Antoine DeschildreUniversity Lille, INSERM Unit 1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Audrey Dunn GalvinAllergy Research Group, University College Cork, Cork, Ireland.
Motohiro EbisawaClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Kanagawa, Japan.
David M FleischerUniversity of Colorado Denver School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
Jennifer GerdtsFood Allergy Canada, Toronto, Ontario, Canada.
Mattia GiovanniniAllergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Josefine GradmanHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Susanne HalkenHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Syed Hasan ArshadClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Ekaterina KhalevaFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0002-2220-7745
Susanne LauDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Richard LohMedical School, The University of Western Australia, Perth, Western Australia, Australia.
Mika J MäkeläSkin and Allergy Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
Mary Jane MarchisottoMJM Advisory, New York, New York, USA.
Laura MorandiniFood Allergy Referral Centre, Department of Women and Children Health, Padua University Hospital, Padua, Italy.
Charlotte G MortzDepartment of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0001-8710-0829
Caroline NilssonDepartment of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Anna Nowak-WegrzynDepartment of Pediatrics, Hassenfeld Children's Hospital, NYU Grossman School of Medicine, New York City, New York, USA.
Marcia PodestàEFA - European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
Lars K PoulsenAllergy Clinic, Copenhagen University Hospital at Herlev-Gentofte, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-1730-847X
Graham RobertsDepartment of Paediatric Allergy and Respiratory Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0003-2252-1248
Pablo Rodríguez Del RíoHospital Infantil Universitario Niño Jesús, Madrid, Spain.
Hugh A SampsonDivision of Allergy and Immunology, Department of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Angel SánchezAEPNAA Spanish Association of People with Food and Latex Allergy, Madrid, Spain.
Sabine SchnadtGerman Allergy and Asthma Association (DAAB), Mönchengladbach, Germany.
Peter K SmithGriffith University School of Medicine, Gold Coast, Queensland, Australia.
Hania SzajewskaDepartment of Paediatrics, Medical University of Warsaw, Warszawa, Poland.
Natasa Teovska MitrevskaDermatology Department, Remedika General Hospital, Skopje, North Macedonia.
Alice TonioloFood Allergy Referral Centre, Department of Women and Children Health, Padua University Hospital, Padua, Italy.
Carina VenterFood Allergy Canada, Toronto, Ontario, Canada.
Amena WarnerAllergy UK, London, UK.
Gary W K WongChinese University of Hong Kong, Hong Kong, Hong Kong.
Robert WoodDepartment of Pediatrics, John Hopkins University School of Medicine, Baltimore, Maryland, USA.
Margitta WormDivision of Allergy and Immunology, Department of Dermatology, Allergy and Venerology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-3449-1245

Funding

Novartis Pharma
6 · The paper itself

Abstract

Immunoglobulin E (IgE)-mediated food allergies are the most common type of food allergy, often causing rapid symptoms after exposure to allergens posing a serious health risk and a high impact on patient's and caregiver's quality of life. Omalizumab, a humanized anti-IgE monoclonal antibody, reduces allergic reactions by binding to circulating IgE. Omalizumab has been successfully used in allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic urticaria, and was recently approved for treating IgE-mediated food allergies by the US Food and Drug Administration (FDA). This GA

Indexed as

anaphylaxisdesensitizationfood allergyimmunoglobulin Eomalizumab

Identifiers

PMID39506193
PMCPMC11540805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.